...
首页> 外文期刊>Nordic journal of psychiatry. >Using brief self-reports and clinician scales to screen for substance use disorders in psychotic patients.
【24h】

Using brief self-reports and clinician scales to screen for substance use disorders in psychotic patients.

机译:使用简短的自我报告和临床医生量表来筛选精神病患者的药物滥用疾病。

获取原文
获取原文并翻译 | 示例
           

摘要

AIMS: The aims of this study were to examine evidence for the concurrent validity of two self-report measures and two staff-report measures measuring alcohol and drug problems in seriously mentally ill people and to examine if psychotic patients under-report their alcohol and drug problems in an early intervention clinic. METHODS: This is a cross-sectional study of 48 patients (26 inpatients and 22 outpatients) from an early intervention clinic for psychosis. To examine the sensitivity and specificity, we compared both the staff-report measures Clinical Alcohol Use Scale (AUS) and Clinical Drug Use Scale (DUS) and the self-report measures Short Michigan Alcohol Screening Test (SMAST-13) and Drug Abuse Screening Test (DAST-20), with the current ICD-10 diagnostic criteria as the gold-standard for alcohol and drug problems. To examine whether the patients under-report their alcohol and drug problems, we also compared the self-report measures SMAST-13 and DAST-20 with the staff-report measures AUS and DUS and ICD-10 consensus substance abuse diagnoses. RESULTS: The results show that the concurrent validity compared with ICD-10 diagnoses was moderate for both the staff-report measures AUS and DUS and for the self-report measures SMAST-13 and DAST-20. Three out of seven patients under-report alcohol problems and one patient out of seven under-report drug use problems according to consensus ICD-10 substance abuse diagnoses. CONCLUSIONS: We conclude that the SMAST-13 and DAST-20 in combination with the AUS and DUS, which are easy and quick to perform, are helpful in establishing a common understanding of the patient's alcohol and drug problems in an early intervention clinic.
机译:目的:本研究的目的是检查证据,以证明两项自我报告措施和两项工作人员报告措施在严重精神疾病患者中测量酒精和毒品问题的同时有效性,并检查精神病患者是否报告酒精和药物不足早期介入诊所的问题。方法:这项横断面研究来自精神病早期干预诊所的48例患者(26例住院患者和22例门诊患者)。为了检查敏感性和特异性,我们比较了工作人员报告的临床酒精使用量表(AUS)和临床药物使用量表(DUS)以及自我报告的密歇根州短酒精筛查测试(SMAST-13)和药物滥用筛查测试(DAST-20),以当前的ICD-10诊断标准为酒精和药物问​​题的金标准。为了检查患者是否报告酒精和药物问​​题,我们还比较了自我报告措施SMAST-13和DAST-20与工作人员报告措施AUS和DUS以及ICD-10共识滥用药物诊断。结果:结果表明,与工作人员报告措施AUS和DUS以及自我报告措施SMAST-13和DAST-20相比,与ICD-10诊断相比,并发有效性中等。根据共识性ICD-10药物滥用诊断,七分之三的患者报告酒精不足,七分之一的患者报告药物滥用不足。结论:我们得出结论,将SMAST-13和DAST-20与AUS和DUS结合使用,操作简便,快速,有助于在早期介入诊所中建立对患者酒精和药物问​​题的共识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号